Pascoflair
Replacement
|
Medicines
|
02/09/2014
In a letter dated September 1, 2014, the marketing authorization holder informed its customers that aflatoxin contamination had been detected in follow-up tests of dry extracts of passionflower herb processed in Pascoflair, which resulted from selective contamination of the drug batches used for extract production.
| Name of the medicinal product | PASCOFLAIR 425 mg - überzogene Tabletten |
|---|---|
| Marketing authorisation number(s) | HERB-00002 |
| Marketing authorisation holder | Pascoe Pharm. Präparate GmbH |
| Batch number(s) | 6559, 6703, 6931 |
| Classification of the recall | 2 |
| BASG reference number | INS - 640.001 - 1 198 |
Further inquiry note
Page last modified:
12/07/2022